362 related articles for article (PubMed ID: 28640996)
1. Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
Yong Y; Zhang C; Gu Z; Du J; Guo Z; Dong X; Xie J; Zhang G; Liu X; Zhao Y
ACS Nano; 2017 Jul; 11(7):7164-7176. PubMed ID: 28640996
[TBL] [Abstract][Full Text] [Related]
2. A GdW
Chen L; Zhang Y; Zhang X; Lv R; Sheng R; Sun R; Du T; Li Y; Qi Y
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011360
[TBL] [Abstract][Full Text] [Related]
3. Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor.
Zhou X; Liu H; Zheng Y; Han Y; Wang T; Zhang H; Sun Q; Li Z
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4231-4240. PubMed ID: 31912727
[TBL] [Abstract][Full Text] [Related]
4. Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.
Clarke RH; Moosa S; Anzivino M; Wang Y; Floyd DH; Purow BW; Lee KS
PLoS One; 2014; 9(10):e111199. PubMed ID: 25350400
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-manipulated radiocatalytic sensitizer based on bismuth heteropolytungstate for radiotherapy enhancement.
Zhou R; Wang H; Yang Y; Zhang C; Dong X; Du J; Yan L; Zhang G; Gu Z; Zhao Y
Biomaterials; 2019 Jan; 189():11-22. PubMed ID: 30384125
[TBL] [Abstract][Full Text] [Related]
6. Bi
Zang Y; Gong L; Mei L; Gu Z; Wang Q
ACS Appl Mater Interfaces; 2019 May; 11(21):18942-18952. PubMed ID: 31058495
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression.
Qi R; Jin W; Wang J; Yi Q; Yu M; Xu S; Jin W
Oncol Rep; 2014 May; 31(5):2399-406. PubMed ID: 24604140
[TBL] [Abstract][Full Text] [Related]
9. KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways.
Oommen D; Prise KM
Biochem Biophys Res Commun; 2012 May; 421(3):538-43. PubMed ID: 22521642
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α.
Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X
J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458
[TBL] [Abstract][Full Text] [Related]
13. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
15. Using YC-1 to overcome the radioresistance of hypoxic cancer cells.
Moon SY; Chang HW; Roh JL; Kim GC; Choi SH; Lee SW; Cho KJ; Nam SY; Kim SY
Oral Oncol; 2009 Oct; 45(10):915-9. PubMed ID: 19457706
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization.
Yang C; Mu G; Zhang Y; Gao Y; Zhang W; Liu J; Zhang W; Li P; Yang L; Yang Z; Gao J; Liu J
Adv Mater; 2022 Sep; 34(37):e2202625. PubMed ID: 35906003
[TBL] [Abstract][Full Text] [Related]
17. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression.
Li N; Meng DD; Gao L; Xu Y; Liu PJ; Tian YW; Yi ZY; Zhang Y; Tie XJ; Xu ZQ
Radiat Oncol; 2018 Oct; 13(1):210. PubMed ID: 30355300
[TBL] [Abstract][Full Text] [Related]
19. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy.
Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q
J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]